Literature DB >> 29948857

Obstructive sleep apnea and the effect of CPAP treatment on ischemia-modified albumin levels: a multi effect size meta-analysis with diagnostic test accuracy.

Seshadri Reddy Varikasuvu1, Naveen Dutt2, Dibakar Sahu3.   

Abstract

PURPOSE: A close association of oxidative stress (OS) and ischemia-modified albumin (IMA) with obstructive sleep apnea (OSA) has been reported in the literature, but the results on IMA are ambiguous. We conducted a meta-analysis to evaluate the association of IMA with OSA and the effect of continuous positive airway pressure (CPAP) therapy on IMA in patients with OSA.
METHODS: Relevant studies were identified by searching PubMed and other databases in addition to manual searching of cross-references. Using random-effects model, the standardized mean differences (SMDs), pooled correlation coefficients and summary of diagnostic test accuracies were obtained with 95% confidence intervals (CIs). The meta-regression, sub-group and sensitivity analyses were performed to explore heterogeneity. The presence of publication bias was tested using funnel plot analysis followed by Begg's and Egger's tests for statistical signidicance.
RESULTS: This meta-analysis finally included nine studies. When comparing with non-OSA controls, the OSA patients showed a significantly increased circulatory IMA levels (SMD = 1.15, p = 0.0001). And, this increase is even more pronounced in severe-OSA group as compared to mild-moderate OSA patients (SMD = 076, p = 0.0006). A decrease in post-CPAP treatment IMA was observed when compared with that of baseline values. Meta-analysis of correlations showed significant associations of IMA with polysomnographic parameters. The pooled diagnostic odds ratio and area under curve were 19.58 and 0.888 (Q* = 0.819), respectively. There was no evidence of publication bias for the association of IMA with OSA.
CONCLUSION: This meta-analysis suggests that OSA is associated with significantly increased IMA levels which may indicate OS, ischemia and subclinical cardiovascular risk. In the diagnostic test accuracy meta-analysis, IMA showed good accuracy for OSA detection. However, further studies are required to establish its clinical utility.

Entities:  

Keywords:  Ischemia-modified albumin; Meta-analysis; Obstructive sleep apnea; Sleep

Mesh:

Substances:

Year:  2018        PMID: 29948857     DOI: 10.1007/s11325-018-1679-6

Source DB:  PubMed          Journal:  Sleep Breath        ISSN: 1520-9512            Impact factor:   2.816


  35 in total

Review 1.  Epidemiology of obstructive sleep apnea: a population health perspective.

Authors:  Terry Young; Paul E Peppard; Daniel J Gottlieb
Journal:  Am J Respir Crit Care Med       Date:  2002-05-01       Impact factor: 21.405

2.  Ischemia-modified albumin as a marker of vascular dysfunction and subclinical atherosclerosis in β-thalassemia major.

Authors:  Amira Abdel Moneam Adly; Nayera Hazaa Khalil ElSherif; Eman Abdel Rahman Ismail; Yosra Abdelzaher Ibrahim; Gamal Niazi; Sara Hamed Elmetwally
Journal:  Redox Rep       Date:  2017-03-13       Impact factor: 4.412

3.  Ischemia-modified albumin levels in overt and subclinical hypothyroidism.

Authors:  S V Reddy; M M Suchitra; V Pradeep; S Alok; V Suresh; A R Bitla; P V L N Srinivasa Rao
Journal:  J Endocrinol Invest       Date:  2015-04-11       Impact factor: 4.256

4.  Serum ischemia-modified albumin level and its association with cardiovascular risk factors in obese children and adolescents.

Authors:  Tamer Baysal; Hayrullah Alp; Nesibe Koç; Mehmet Emre Atabek; Beray Selver Eklioğlu; Sevim Karaarslan
Journal:  J Pediatr Endocrinol Metab       Date:  2012       Impact factor: 1.634

5.  Assessment of the role of serum ischemia-modified albumin in obstructive sleep apnea in comparison with interleukin-6.

Authors:  Deniz Dogan; Nesrin Ocal; Mehmet Aydogan; Canturk Tasci; Yakup Arslan; Serkan Tapan; Sinan Yetkin; Hayati Bilgic
Journal:  Postgrad Med       Date:  2016-06-26       Impact factor: 3.840

6.  Ischemia modified albumin (IMA) and albumin adjusted-IMA (AAIMA) as biomarkers for diabetic retinopathy.

Authors:  Varikasuvu Seshadri Reddy; Sumita Sethi; Poonam Agrawal; Navdeep Gupta; Renu Garg
Journal:  Nepal J Ophthalmol       Date:  2015-07

7.  Effect of Continuous Positive Airway Pressure on Cardiovascular Biomarkers: The Sleep Apnea Stress Randomized Controlled Trial.

Authors:  Hugo L Paz Y Mar; Stanley L Hazen; Russell P Tracy; Kingman P Strohl; Dennis Auckley; James Bena; Lu Wang; Harneet K Walia; Sanjay R Patel; Reena Mehra
Journal:  Chest       Date:  2016-03-18       Impact factor: 9.410

Review 8.  Molecular mechanisms of cardiovascular disease in OSAHS: the oxidative stress link.

Authors:  L Lavie; P Lavie
Journal:  Eur Respir J       Date:  2009-06       Impact factor: 16.671

9.  Advanced oxidation protein products and ischaemia-modified albumin in obstructive sleep apnea.

Authors:  Serkan Ozben; Nergiz Huseyinoglu; Ferhat Hanikoglu; Tolga Sinan Guvenc; Binnaz Zeynep Yildirim; Aysegul Cort; Sebahat Ozdem; Tomris Ozben
Journal:  Eur J Clin Invest       Date:  2014-10-04       Impact factor: 4.686

10.  QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies.

Authors:  Penny F Whiting; Anne W S Rutjes; Marie E Westwood; Susan Mallett; Jonathan J Deeks; Johannes B Reitsma; Mariska M G Leeflang; Jonathan A C Sterne; Patrick M M Bossuyt
Journal:  Ann Intern Med       Date:  2011-10-18       Impact factor: 25.391

View more
  1 in total

1.  NOX4, MDA, IMA and oxidative DNA damage: can these parameters be used to estimate the presence and severity of OSA?

Authors:  Selami Ekin; Hanifi Yildiz; Hamit Hakan Alp
Journal:  Sleep Breath       Date:  2020-05-12       Impact factor: 2.816

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.